The role of nuclear imaging in the failing heart: Myocardial blood flow, sympathetic innervation, and future applications

Heart Failure Reviews

Volumn 16, Issue 4, 2011, Pages 411-423

  Boogers, Mark J ^a,b   Fukushima, Kenji ^c   Bengel, Frank M ^c   Bax, Jeroen J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Heart failure; Myocardial blood flow; Nuclear imaging; Sympathetic innervation

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; AMMONIA N 13; FLURPIRIDAZ F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RUBIDIUM 82; TETROFOSMIN TC 99M; THALLIUM 201; WATER O 15;

ARTICLE; CARDIAC IMAGING; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY OBSTRUCTION; DRUG HALF LIFE; FIRST PASS EFFECT; HEART FAILURE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE PERFUSION; HOMEOSTASIS; HUMAN; MORBIDITY; MORTALITY; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; SEX DIFFERENCE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPATHETIC INNERVATION;

HEART FAILURE; HEMODYNAMICS; HUMANS; MOLECULAR IMAGING; MYOCARDIUM; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; SYMPATHETIC NERVOUS SYSTEM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 80052525846     PISSN: 13824147     EISSN: 15737322     Source Type: Journal    
DOI: 10.1007/s10741-010-9196-0     Document Type: Article

References (75)

1. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW (2009) 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119: 391-479
2. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, Kittner S, Lloyd- Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell C, Roger V, Sorlie P, Steinberger J, Thom T, Wilson M, Hong Y (2008) Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117:25-146
3. Levy D, Kenchaiah S, Larson MG, Benjamin EJ, Kupka MJ, Ho KK, Murabito JM, Vasan RS (2002) Long-term trends in the incidence of and survival with heart failure. N Engl J Med 347:1397-1402 (Pubitemid 35239711)
4. Bristow MR (1984) The adrenergic nervous system in heart failure. N Engl J Med 311:850-851 (Pubitemid 14035095)
5. Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL (2001) Principles of internal medicine. Harrison's 15:1316-1323
6. Mann DL, Bristow MR (2005) Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation 111:2837-2849 (Pubitemid 40791557)
7. Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G, Butler J (2009) The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. J Am Coll Cardiol 54:1747-1762
8. Flotats A, Carrio I (2004) Cardiac neurotransmission SPECT imaging. J Nucl Cardiol 11:587-602 (Pubitemid 39341804)
9. Bengel FM, Higuchi T, Javadi MS, Lautamaki R (2009) Cardiac positron emission tomography. J Am Coll Cardiol 54:1-15
10. Hendel RC, Berman DS, Di Carli MF, Heidenreich PA, Henkin RE, Pellikka PA, Pohost GM, Williams KA (2009) ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 appropriate use criteria for cardiac radionuclide imaging: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine. Circulation 119:561-587
11. Underwood SR, Anagnostopoulos C, Cerqueira M, Ell PJ, Flint EJ, Harbinson M, Kelion AD, Al-Mohammad A, Prvulovich EM, Shaw LJ, Tweddel AC (2004) Myocardial perfusion scintigraphy: the evidence. Eur J Nucl Med Mol Imaging 31:261-291
12. Di Carli MF, Dorbala S, Meserve J, El FG, Sitek A, Moore SC (2007) Clinical myocardial perfusion PET/CT. J Nucl Med 48:783-793 (Pubitemid 47604980)
13. Higuchi T, Nekolla SG, Huisman MM, Reder S, Poethko T, Yu M, Wester HJ, Casebier DS, Robinson SP, Botnar RM, Schwaiger M (2008) A new 18F-labeled myocardial PET tracer: myocardial uptake after permanent and transient coronary occlusion in rats. J Nucl Med 49:1715-1722
14. Nekolla SG, Reder S, Saraste A, Higuchi T, Dzewas G, Preissel A, Huisman M, Poethko T, Schuster T, Yu M, Robinson S, Casebier D, Henke J, Wester HJ, Schwaiger M (2009) Evaluation of the novel myocardial perfusion positron-emission tomography tracer 18F-BMS-747158-02: comparison to 13N-ammonia and validation with microspheres in a pig model. Circulation 119: 2333-2342
15. Yoshida K, Mullani N, Gould KL (1996) Coronary flow and flow reserve by PET simplified for clinical applications using rubidium- 82 or nitrogen-13-ammonia. J Nucl Med 37:1701-1712 (Pubitemid 26337184)
16. Lautamaki R, George RT, Kitagawa K, Higuchi T, Merrill J, Voicu C, DiPaula A, Nekolla SG, Lima JA, Lardo AC, Bengel FM (2009) Rubidium-82 PET-CT for quantitative assessment of myocardial blood flow: validation in a canine model of coronary artery stenosis. Eur J Nucl Med Mol Imag 36:576-586
17. Nitzsche EU, Choi Y, Czernin J, Hoh CK, Huang SC, Schelbert HR (1996) Noninvasive quantification of myocardial blood flow in humans. A direct comparison of the [13N]ammonia and the [150]water techniques. Circulation 93:2000-2006
18. Gerber BL, Melin JA, Bol A, Labar D, Cogneau M, Michel C, Vanoverschelde JL (1998) Nitrogen-13-ammonia and oxygen-15-water estimates of absolute myocardial perfusion in left ventricular ischemic dysfunction. J Nucl Med 39:1655-1662 (Pubitemid 28473507)
19. El FG, Kardan A, Sitek A, Dorbala S, bi-Hatem N, Lahoud Y, Fischman A, Coughlan M, Yasuda T, Di Carli MF (2009) Reproducibility and accuracy of quantitative myocardial blood flow assessment with (82)Rb PET: comparison with (13)Nammonia PET. J Nucl Med 50:1062-1071
20. Czernin J, Muller P, Chan S, Brunken RC, Porenta G, Krivokapich J, Chen K, Chan A, Phelps ME, Schelbert HR (1993) Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation 88:62-69 (Pubitemid 23195433)
21. Gould KL, Martucci JP, Goldberg DI, Hess MJ, Edens RP, Latifi R, Dudrick SJ (1994) Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvasive marker of healing coronary endothelium. Circulation 89:1530-1538
22. Kaufmann PA, Gnecchi-Ruscone T, di TM, Schafers KP, Luscher TF, Camici PG (2000) Coronary heart disease in smokers: vitamin C restores coronary microcirculatory function. Circulation 102:1233-1238
23. Herzog BA, Husmann L, Valenta I, Gaemperli O, Siegrist PT, Tay FM, Burkhard N, Wyss CA, Kaufmann PA (2009) Longterm prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. J Am Coll Cardiol 54:150-156
24. Tio RA, Dabeshlim A, Siebelink HM, De SJ, Hillege HL, Zeebregts CJ, Dierckx RA, van Veldhuisen DJ, Zijlstra F, Slart RH (2009) Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease. J Nucl Med 50:214-219
25. van den Heuvel AF, van Veldhuisen DJ, van der Wall EE, Blanksma PK, Siebelink HM, Vaalburg WM, van Gilst WH, Crijns HJ (2000) Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 35:19-28 (Pubitemid 30061254)
26. Stolen KQ, Kemppainen J, Kalliokoski KK, Karanko H, Toikka J, Janatuinen T, Raitakari OT, Airaksinen KE, Nuutila P, Knuuti J (2004) Myocardial perfusion reserve and peripheral endothelial function in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 93:64-68 (Pubitemid 38022035)
27. Weiss MB, Ellis K, Sciacca RR, Johnson LL, Schmidt DH, Cannon PJ (1976) Myocardial blood flow in congestive and hypertrophic cardiomyopathy: relationship to peak wall stress and mean velocity of circumferential fiber shortening. Circulation 54:484-494
28. Neglia D, Michelassi C, Trivieri MG, Sambuceti G, Giorgetti A, Pratali L, Gallopin M, Salvadori P, Sorace O, Carpeggiani C, Poddighe R, L'Abbate A, Parodi O (2002) Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation 105:186-193 (Pubitemid 34084317)
29. Cecchi F, Olivotto I, Gistri R, Lorenzoni R, Chiriatti G, Camici PG (2003) Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 349:1027-1035 (Pubitemid 37087617)
30. Langer O, Halldin C (2002) PET and SPET tracers for mapping the cardiac nervous system. Eur J Nucl Med Mol Imag 29:416-434 (Pubitemid 34253256)
31. Agostini D, Verberne HJ, Burchert W, Knuuti J, Povinec P, Sambuceti G, Unlu M, Estorch M, Banerjee G, Jacobson AF (2008) I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study. Eur J Nucl Med Mol Imag 35:535-546
32. Verberne HJ, Brewster LM, Somsen GA, Van Eck-Smit BL (2008) Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review. Eur Heart J 29:1147-1159 (Pubitemid 351844881)
33. Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, Agostini D, Weiland F, Chandna H, Narula J (2010) Myocardial Iodine-123 Meta-Iodobenzylguanidine Imaging and Cardiac Events in Heart Failure Results of the Prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) Study. J Am Coll Cardiol 55:2212-2221
34. Merlet P, Valette H, Dubois-Rande JL, Moyse D, Duboc D, Dove P, Bourguignon MH, Benvenuti C, Duval AM, Agostini D (1992) Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 33:471-477
35. Merlet P, Benvenuti C, Moyse D, Pouillart F, Dubois-Rande JL, Duval AM, Loisance D, Castaigne A, Syrota A (1999) Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J Nucl Med 40:917-923 (Pubitemid 29269210)
36. Flotats A, Carrio I, Agostini D, Le GD, Marcassa C, Schaffers M, Somsen GA, Unlu M, Verberne HJ (2010) Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imag 37:1802-1812
37. Anastasiou-Nana MI, Terrovitis JV, Athanasoulis T, Karaloizos L, Geramoutsos A, Pappa L, Tsagalou EP, Efentakis S, Nanas JN (2005) Prognostic value of iodine-123-metaiodobenzylguanidine myocardial uptake and heart rate variability in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 96:427-431 (Pubitemid 41058876)
38. Momose M, Kobayashi H, Iguchi N, Matsuda N, Sakomura Y, Kasanuki H, Kusakabe K, Okawa T (1999) Comparison of parameters of 123I-MIBG scintigraphy for predicting prognosis in patients with dilated cardiomyopathy. Nucl Med Commun 20:529-535 (Pubitemid 29509990)
39. Ogita H, Shimonagata T, Fukunami M, Kumagai K, Yamada T, Asano Y, Hirata A, Asai M, Kusuoka H, Hori M, Hoki N (2001) Prognostic significance of cardiac (123)I metaiodobenzylguanidine imaging for mortality and morbidity in patients with chronic heart failure: a prospective study. Heart 86:656-660 (Pubitemid 33086883)
40. Yamada T, Shimonagata T, Fukunami M, Kumagai K, Ogita H, Hirata A, Asai M, Makino N, Kioka H, Kusuoka H, Hori M, Hoki N (2003) Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure: a prospective study. J Am Coll Cardiol 41:231-238 (Pubitemid 36092191)
41. Podrid PJ, Fuchs T, Candinas R (1990) Role of the sympathetic nervous system in the genesis of ventricular arrhythmia. Circulation 82:103-113
42. Kammerling JJ, Green FJ, Watanabe AM, Inoue H, Barber MJ, Henry DP, Zipes DP (1987) Denervation supersensitivity of refractoriness in noninfarcted areas apical to transmural myocardial infarction. Circulation 76:383-393 (Pubitemid 17124749)
43. Schafers M, Wichter T, Lerch H, Matheja P, Kuwert T, Schafers K, Borggrefe M, Breithardt G, Schober O (1999) Cardiac 123IMIBG uptake in idiopathic ventricular tachycardia and fibrillation. J Nucl Med 40:1-5 (Pubitemid 29044163)
44. Paul M, Schafers M, Kies P, Acil T, Schafers K, Breithardt G, Schober O, Wichter T (2006) Impact of sympathetic innervation on recurrent life-threatening arrhythmias in the follow-up of patients with idiopathic ventricular fibrillation. Eur J Nucl Med Mol Imag 33:866-870 (Pubitemid 44127434)
45. Tamaki S, Yamada T, Okuyama Y, Morita T, Sanada S, Tsukamoto Y, Masuda M, Okuda K, Iwasaki Y, Yasui T, Hori M, Fukunami M (2009) Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion. J Am Coll Cardiol 53:426-435
46. Nagahara D, Nakata T, Hashimoto A, Wakabayashi T, Kyuma M, Noda R, Shimoshige S, Uno K, Tsuchihashi K, Shimamoto K (2008) Predicting the need for an implantable cardioverter defibrillator using cardiac metaiodobenzylguanidine activity together with plasma natriuretic peptide concentration or left ventricular function. J Nucl Med 49:225-233 (Pubitemid 351225660)
47. Boogers MJ, Borleffs CJW, Henneman MM, Van Bommel RJ, Van Ramshorst J, Boersma E, Dibbets-Schneider P, Stokkel MP, van der Wall EE, Schalij MJ, Bax JJ (2010) Cardiac sympathetic denervation assessed with 123-I MIBG imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients. J Am Coll Cardiol 55:2769-2777
48. Zipes DP (1991) Sympathetic stimulation and arrhythmias. N Engl J Med 325:656-657
49. Desantiago J, Ai X, Islam M, Acuna G, Ziolo MT, Bers DM, Pogwizd SM (2008) Arrhythmogenic effects of beta2-adrenergic stimulation in the failing heart are attributable to enhanced sarcoplasmic reticulum Ca load. Circ Res 102:1389-1397
50. Ungerer M, Hartmann F, Karoglan M, Chlistalla A, Ziegler S, Richardt G, Overbeck M, Meisner H, Schomig A, Schwaiger M (1998) Regional in vivo and in vitro characterization of autonomic innervation in cardiomyopathic human heart. Circulation 97:174-180 (Pubitemid 28124675)
51. Hartmann F, Ziegler S, Nekolla S, Hadamitzky M, Seyfarth M, Richardt G, Schwaiger M (1999) Regional patterns of myocardial sympathetic denervation in dilated cardiomyopathy: an analysis using carbon-11 hydroxyephedrine and positron emission tomography. Heart 81:262-270 (Pubitemid 29116337)
52. Vesalainen RK, Pietila M, Tahvanainen KU, Jartti T, Teras M, Nagren K, Lehikoinen P, Huupponen R, Ukkonen H, Saraste M, Knuuti J, Voipio-Pulkki LM (1999) Cardiac positron emission tomography imaging with [11C]hydroxyephedrine, a specific tracer for sympathetic nerve endings, and its functional correlates in congestive heart failure. Am J Cardiol 84:568-574 (Pubitemid 29408590)
53. Pietila M, Malminiemi K, Ukkonen H, Saraste M, Nagren K, Lehikoinen P, Voipio-Pulkki LM (2001) Reduced myocardial carbon-11 hydroxyephedrine retention is associated with poor prognosis in chronic heart failure. Eur J Nucl Med 28:373-376
54. Bengel FM, Ueberfuhr P, Schiepel N, Nekolla SG, Reichart B, Schwaiger M (2001) Myocardial efficiency and sympathetic reinnervation after orthotopic heart transplantation: a noninvasive study with positron emission tomography. Circulation 103:1881-1886 (Pubitemid 32328402)
55. Bengel FM, Permanetter B, Ungerer M, Nekolla SG, Schwaiger M (2002) Alterations of the sympathetic nervous system and metabolic performance of the cardiomyopathic heart. Eur J Nucl Med Mol Imag 29:198-202
56. Bengel FM, Ueberfuhr P, Hesse T, Schiepel N, Ziegler SI, Scholz S, Nekolla SG, Reichart B, Schwaiger M (2002) Clinical determinants of ventricular sympathetic reinnervation after orthotopic heart transplantation. Circulation 106:831-835
57. Di Carli MF, Tobes MC, Mangner T, Levine AB, Muzik O, Chakroborty P, Levine TB (1997) Effects of cardiac sympathetic innervation on coronary blood flow. N Engl J Med 336:1208-1215 (Pubitemid 27183650)
58. Sasano T, Abraham MR, Chang KC, Ashikaga H, Mills KJ, Holt DP, Hilton J, Nekolla SG, Dong J, Lardo AC, Halperin H, Dannals RF, Marban E, Bengel FM (2008) Abnormal sympathetic innervation of viable myocardium and the substrate of ventricular tachycardia after myocardial infarction. J Am Coll Cardiol 51:2266-2275 (Pubitemid 351754990)
59. Mann DL, Spinale FG (1998) Activation of matrix metalloproteinases in the failing human heart: breaking the tie that binds. Circulation 98:1699-1702 (Pubitemid 28492487)
60. Mukherjee R, Brinsa TA, Dowdy KB, Scott AA, Baskin JM, Deschamps AM, Lowry AS, Escobar GP, Lucas DG, Yarbrough WM, Zile MR, Spinale FG (2003) Myocardial infarct expansion and matrix metalloproteinase inhibition. Circulation 107:618-625 (Pubitemid 36176814)
61. Su H, Spinale FG, Dobrucki LW, Song J, Hua J, Sweterlitsch S, Dione DP, Cavaliere P, Chow C, Bourke BN, Hu XY, Azure M, Yalamanchili P, Liu R, Cheesman EH, Robinson S, Edwards DS, Sinusas AJ (2005) Noninvasive targeted imaging of matrix metalloproteinase activation in a murine model of postinfarction remodeling. Circulation 112:3157-3167
62. Peterson LR, Gropler RJ (2010) Radionuclide imaging of myocardial metabolism. Circ Cardiovasc Imag 3:211-222
63. Lautamaki R, Tipre D, Bengel FM (2007) Cardiac sympathetic neuronal imaging using PET. Eur J Nucl Med Mol Imag 34:S74-S85 (Pubitemid 46957471)
64. Verjans JW, Lovhaug D, Narula N, Petrov AD, Indrevoll B, Bjurgert E, Krasieva TB, Petersen LB, Kindberg GM, Solbakken M, Cuthbertson A, Vannan MA, Reutelingsperger CP, Tromberg BJ, Hofstra L, Narula J (2008) Noninvasive imaging of angiotensin receptors after myocardial infarction. JACC Cardiovasc Imag 1:354-362 (Pubitemid 351676844)
65. Meoli DF, Sadeghi MM, Krassilnikova S, Bourke BN, Giordano FJ, Dione DP, Su H, Edwards DS, Liu S, Harris TD, Madri JA, Zaret BL, Sinusas AJ (2004) Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction. J Clin Invest 113:1684-1691 (Pubitemid 39071660)
66. Higuchi T, Bengel FM, Seidl S, Watzlowik P, Kessler H, Hegenloh R, Reder S, Nekolla SG, Wester HJ, Schwaiger M (2008) Assessment of alphavbeta3 integrin expression after myocardial infarction by positron emission tomography. Cardiovasc Res 78:395-403 (Pubitemid 351556104)
67. Rodriguez-Porcel M, Cai W, Gheysens O, Willmann JK, Chen K, Wang H, Chen IY, He L, Wu JC, Li ZB, Mohamedali KA, Kim S, Rosenblum MG, Chen X, Gambhir SS (2008) Imaging of VEGF receptor in a rat myocardial infarction model using PET. J Nucl Med 49:667-673 (Pubitemid 351520616)
68. Kramer CM, Sinusas AJ, Sosnovik DE, French BA, Bengel FM (2010) Multimodality imaging of myocardial injury and remodeling. J Nucl Med 51:107S-121S
69. Kraitchman DL, Heldman AW, Atalar E, Amado LC, Martin BJ, Pittenger MF, Hare JM, Bulte JW (2003) In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 107:2290-2293 (Pubitemid 36578497)
70. Brenner W, Aicher A, Eckey T, Massoudi S, Zuhayra M, Koehl U, Heeschen C, Kampen WU, Zeiher AM, Dimmeler S, Henze E (2004) 111In-labeled CD34? hematopoietic progenitor cells in a rat myocardial infarction model. J Nucl Med 45:512-518 (Pubitemid 47618629)
71. Hofmann M, Wollert KC, Meyer GP, Menke A, Arseniev L, Hertenstein B, Ganser A, Knapp WH, Drexler H (2005) Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 111:2198-2202 (Pubitemid 40632435)
72. Bengel FM, Anton M, Richter T, Simoes MV, Haubner R, Henke J, Erhardt W, Reder S, Lehner T, Brandau W, Boekstegers P, Nekolla SG, Gansbacher B, Schwaiger M (2003) Noninvasive imaging of transgene expression by use of positron emission tomography in a pig model of myocardial gene transfer. Circulation 108:2127-2133 (Pubitemid 37337590)
73. Higuchi T, Anton M, Dumler K, Seidl S, Pelisek J, Saraste A, Welling A, Hofmann F, Oostendorp RA, Gansbacher B, Nekolla SG, Bengel FM, Botnar RM, Schwaiger M (2009) Combined reporter gene PET and iron oxide MRI for monitoring survival and localization of transplanted cells in the rat heart. J Nucl Med 50:1088-1094
74. Terrovitis J, Kwok KF, Lautamaki R, Engles JM, Barth AS, Kizana E, Miake J, Leppo MK, Fox J, Seidel J, Pomper M, Wahl RL, Tsui B, Bengel F, Marban E, Abraham MR (2008) Ectopic expression of the sodium-iodide symporter enables imaging of transplanted cardiac stem cells in vivo by single-photon emission computed tomography or positron emission tomography. J Am Coll Cardiol 52:1652-1660
75. Terrovitis J, Lautamaki R, Bonios M, Fox J, Engles JM, Yu J, Leppo MK, Pomper MG, Wahl RL, Seidel J, Tsui BM, Bengel FM, Abraham MR, Marban E (2009) Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery. J Am Coll Cardiol 54:1619-1626